Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
Authors:
- Anna SalvatiASAnna Salvati
- Andrzej S. PitekAPAndrzej S. Pitek
- Marco P. MonopoliMarco P. Monopoli
- Kanlaya PrapainopKPKanlaya Prapainop
- Francesca Baldelli BombelliFBFrancesca Baldelli Bombelli
- Delyan R. HristovDHDelyan R. Hristov
- Philip M. KellyPKPhilip M. Kelly
- Christoffer ÅbergCÅChristoffer Åberg
- Eugene MahonEMEugene Mahon
- Kenneth A. DawsonKDKenneth A. Dawson
Top Cited Papers
- 20 January 2013
- journal article
- research article
- Published by Springer Nature in Nature Nanotechnology
- Vol. 8 (2) , 137-143
Abstract
Nanoparticles have been proposed as carriers for drugs, genes and therapies to treat various diseases. Many strategies have been developed to target nanomaterials to specific or over-expressed receptors in diseased cells, and these typically involve functionalizing the surface of nanoparticles with proteins, antibodies or other biomolecules. Here, we show that the targeting ability of such functionalized nanoparticles may disappear when they are placed in a biological environment. Using transferrin-conjugated nanoparticles, we found that proteins in the media can shield transferrin from binding to both its targeted receptors on cells and soluble transferrin receptors. Although nanoparticles continue to enter cells, the targeting specificity of transferrin is lost. Our results suggest that when nanoparticles are placed in a complex biological environment, interaction with other proteins in the medium and the formation of a protein corona can 'screen' the targeting molecules on the surface of nanoparticles and cause loss of specificity in targeting.Keywords
This publication has 35 references indexed in Scilit:
- Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kineticsNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammationNature Nanotechnology, 2010
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Frontiers in cancer nanomedicine: directing mass transport through biological barriersTrends in Biotechnology, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- Targeting of drugs and nanoparticles to tumorsJournal of Cell Biology, 2010
- Physical approaches to biomaterial designNature Materials, 2009
- Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubesProceedings of the National Academy of Sciences, 2008
- Direct evidence for rapid and selective induction of tumor neovascular permeability by tumor necrosis factor and a novel derivative, colloidal gold bound tumor necrosis factorInternational Journal of Cancer, 2007
- Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticlesProceedings of the National Academy of Sciences of the United States of America, 2007